Self-aggregation of verteporfin in glioblastoma multiforme cells: a static and time-resolved fluorescence study
Source abstract
Abstract
Abstract Monomeric state of photosensitizer molecules can induce biological responses in a variety of neoplastic tissues in photodynamic therapy, but the self-aggregate forms are mostly inactive. Although verteporfin has showed a history of success as a photosensitizer, its self-aggregation inside cancer cells has not been fully described. This study aimed to elucidate the self-aggregation of verteporfin in glioblastoma multiforme cells at various concentrations, using steady-state/time-resolved fluorescence and fluorescence lifetime imaging microscopy based on our previous approach (Calori and Tedesco, 2020). According to the findings, low internalization mainly led to the monomeric state of verteporfin inside cells, with a fluorescence lifetime of ~6.0 ns. J-type fluorescent self-aggregates of verteporfin were found in intermediate conditions, in coexistence with monomers, presenting a lower fluorescence lifetime of ~2.5 ns. At high internalization of verteporfin, the amount of self-aggregates increased and the monomer's lifetime decreased, showing the dependence of the aggregation of verteporfin on concentration. The findings suggest that the amount of monomers of verteporfin inside cells reaches a saturation limit. This limitation could be a critical factor in photodynamic therapy that uses poor intracellular soluble photosensitizers.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
2. Update of the situation of clinical photodynamic therapy in Europe in the 2003–2018 period10.1142/S1088424619300027 ↗
3. Intra-arterial drug and light delivery for photodynamic therapy using Visudyne®: implication for atherosclerotic plaque treatment10.3389/fphys.2016.00400 ↗
4. Photodynamic therapy for onychomycosis: a systematic review10.1016/j.pdpdt.2016.07.010 ↗
5. An open label, phase II trial of continuous low-irradiance photodynamic therapy (CLIPT) using verteporfin for the treatment of cutaneous breast cancer metastases
6. Photodynamic therapy for the treatment of vertebral metastases: a phase I clinical trial10.1158/1078-0432.CCR-19-0673 ↗
7. Verteporfin-loaded polymeric microparticles for intratumoral treatment of Brain cancer10.1021/acs.molpharmaceut.8b00959 ↗
8. Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma10.1038/s41419-019-1989-z ↗
9. Verteporfin targeting YAP1/TAZ‐TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells10.1002/ijc.32667 ↗
10. Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function10.7150/ijbs.29135 ↗
11. Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency10.1200/JCO.2016.66.6552 ↗
12. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD‐MA)10.1111/j.1751-1097.1994.tb05042.x ↗
13. Photosensitizers used in the photodynamic therapy of rheumatoid arthritis10.3390/ijms20133339 ↗
14. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
15. Sulfonated phthalocyanines: aggregation and singlet oxygen quantum yield in aqueous solutions10.1142/S1088424603000203 ↗
16. Quantum yield of singlet oxygen production by monomeric and aggregated forms of hematoporphyrin derivative10.1016/S0891-5849(00)00460-3 ↗
17. Studies of a benzoporphyrin derivative with Pluronics10.1139/v02-167 ↗
18. Formulation of benzoporphyrin derivatives in pluronics10.1562/0031-8655(2003)077<0299:FOBDIP>2.0.CO;2 ↗
19. Pluronic® mixed micelles as efficient nanocarriers for benzoporphyrin derivatives applied to photodynamic therapy in cancer cells
20. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD‐MA)10.1111/j.1751-1097.1994.tb05042.x ↗
21. Verteporfin-loaded poly (ethylene glycol)-poly (beta-amino ester)-poly (ethylene glycol) triblock micelles for cancer therapy10.1021/acs.biomac.8b00640 ↗
22. Lipid vesicles loading aluminum phthalocyanine chloride: formulation properties and disaggregation upon intracellular delivery10.1016/j.jphotobiol.2016.03.050 ↗
23. Aluminum chloride phthalocyanine in MCF-7: rationally accounting for state of aggregation of photosensitizers inside cells10.1016/j.dyepig.2019.107940 ↗
24. Circular dichroism spectroscopy as a powerful tool for unraveling assembly of chiral nonluminescent aggregates of photosensitizer molecules on nanoparticle surfaces10.1021/acs.jpca.9b05500 ↗
25. New insights about the self-aggregation of benzoporphyrin derivatives: a theoretical and experimental investigation10.1142/S1088424618500311 ↗
26. Aggregation state of amphiphilic cationic tetraphenylporphyrin derivatives in aqueous microheterogeneous systems10.1007/s11172-015-0937-z ↗
27. Characterization of fluorescence lifetime of photofrin and delta-aminolevulinic acid induced protoporphyrin IX in living cells using single-and two-photon excitation10.1109/JSTQE.2007.912896 ↗
28. Water-soluble metal naphthalocyanines—near-IR photosensitizers: cellular uptake, toxicity and photosensitizing properties in NHIK 3025 human cancer cells10.1016/1011-1344(90)85017-Q ↗
29. Evaluation of a chloroaluminium phthalocyanine-loaded magnetic nanoemulsion as a drug delivery device to treat glioblastoma using hyperthermia and photodynamic therapy10.1039/C6RA26105A ↗
30. Lakowicz · 2013
31. Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells10.2147/IJN.S103344 ↗
32. New views on cellular uptake and trafficking of manufactured nanoparticles10.1098/rsif.2012.0939 ↗
33. Fluorescence aggregation-caused quenching versus aggregation-induced emission: a visual teaching technology for undergraduate chemistry students10.1021/acs.jchemed.5b00483 ↗
34. Aspmodal I. Effekt av lavdoserate< beta>-bestråling på T98G humane kreftceller i kultur 2011.
35. Fluorescent J-aggregates of cyanine dyes: basic research and applications review10.1088/2050-6120/aa8d0d ↗
36. J-aggregation of a sulfur-substituted naphthalenediimide (NDI) with remarkably bright fluorescence10.1039/C6CC03493D ↗
37. Characterization of the long-range internal dynamics of pyrene-labeled macromolecules by pyrene excimer fluorescence10.1021/acs.macromol.6b02455 ↗
38. Fluorescence properties and exciplex formation of emissive naphthyridine derivatives: application as sensors for amines10.1002/chem.201903643 ↗
39. Phthalocyanine fluorescence at high concentration: dimers or reabsorption effect?
40. Deconvolution of non-exponential emission decays arising from reabsorption of emitted light
41. Bünau · 1970 · 74 · 1294
42. Characterization of fluorescence lifetime of photofrin and delta-aminolevulinic acid induced protoporphyrin IX in living cells using single-and two-photon excitation
43. Fluorescent H-aggregates of an asymmetrically substituted mono-amino Zn (II) phthalocyanine10.1039/C6DT02651F ↗
44. Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells10.1016/j.msec.2016.09.064 ↗
45. Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers10.1016/j.msec.2016.05.047 ↗
46. Experimental evaluation of the density of water in a cell by Raman microscopy10.1021/acs.jpclett.7b02154 ↗
47. Function of metabolic and organelle networks in crowded and organized media10.3389/fphys.2014.00523 ↗
48. Investigation of novel substituted zinc and aluminium phthalocyanines for photodynamic therapy of epithelial breast cancer10.1016/j.dyepig.2019.107592 ↗
49. Soluble axially substituted phthalocyanines: synthesis and nonlinear optical response10.1007/s10853-006-5552-9 ↗
50. Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors10.1111/j.1751-1097.1986.tb05648.x ↗
51. Enhanced efficiency of cell death by lysosome-specific photodamage10.1038/s41598-017-06788-7 ↗